Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience

Wed, 02 Sep 2026 07:00:00 -0400

Multicenter retrospective case series published in Ophthalmology and Therapy
Results demonstrate enVista Aspire and enVista Aspire toric deliver good distance and functional intermediate vision in a majority of patients
Study shows these enhanced monofocal lenses can meet digital demands modern cataract patients face
This paper and other data on enVista Aspire can be found on Bausch + Lomb’s new Eye Care Professional Hub

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the

Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience

Wed, 02 Sep 2026 07:00:00 -0400

Multicenter retrospective case series published in Ophthalmology and Therapy

Results demonstrate enVista Aspire and enVista Aspire toric deliver good distance and functional intermediate vision in a majority of patients

Study shows these enhanced monofocal lenses can meet digital demands modern cataract patients face

This paper and other data on enVista Aspire can be found on Bausch + Lomb’s new Eye Care Professional Hub

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the

Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience

Wed, 02 Sep 2026 07:00:00 -0400

Multicenter retrospective case series published in Ophthalmology and Therapy

Results demonstrate enVista Aspire and enVista Aspire toric deliver good distance and functional intermediate vision in a majority of patients

Study shows these enhanced monofocal lenses can meet digital demands modern cataract patients face

This paper and other data on enVista Aspire can be found on Bausch + Lomb’s new Eye Care Professional Hub

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the

Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience

Wed, 02 Sep 2026 07:00:00 -0400

Multicenter retrospective case series published in Ophthalmology and Therapy

Results demonstrate enVista Aspire and enVista Aspire toric deliver good distance and functional intermediate vision in a majority of patients

Study shows these enhanced monofocal lenses can meet digital demands modern cataract patients face

This paper and other data on enVista Aspire can be found on Bausch + Lomb’s new Eye Care Professional Hub

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the

Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience

Wed, 02 Sep 2026 07:00:00 -0400

Multicenter retrospective case series published in Ophthalmology and Therapy

Results demonstrate enVista Aspire and enVista Aspire toric deliver good distance and functional intermediate vision in a majority of patients

Study shows these enhanced monofocal lenses can meet digital demands modern cataract patients face

This paper and other data on enVista Aspire can be found on Bausch + Lomb’s new Eye Care Professional Hub

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the

Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience

Wed, 02 Sep 2026 07:00:00 -0400

Multicenter retrospective case series published in Ophthalmology and Therapy

Results demonstrate enVista Aspire and enVista Aspire toric deliver good distance and functional intermediate vision in a majority of patients

Study shows these enhanced monofocal lenses can meet digital demands modern cataract patients face

This paper and other data on enVista Aspire can be found on Bausch + Lomb’s new Eye Care Professional Hub

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the

Bausch Health's Solta Medical launches Fraxel FTX skin device in Australia

Tue, 01 Sep 2026 08:02:01 -0400

Bausch Health Companies Inc. (NYSE: BHC) announced that its aesthetics unit, Solta Medical, has made the Fraxel FTX® laser system available to health care practitioners in Australia as of September 1, 2026.

The Fraxel FTX is a skin resurfacing device that uses dual wavelengths — 1550 nanometers and 1927 nanometers — to treat different tissue depths. It is indicated for conditions including acne scars, surgical scars, actinic keratosis, dyschromia such as melasma, lentigos, ephelides, and the appearance of fine lines and wrinkles.

The system includes a redesigned handpiece with a 20% reduction in circumference and weight compared to its predecessor, along with

Bausch Health Announces Availability of Solta Medical's Fraxel FTX® in Australia

Tue, 01 Sep 2026 08:01:00 -0400

The next generation in skin resurfacing technology is available to Australian health care practitioners beginning September 1, 2026

LAVAL, QC, Sept. 1, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC), a global, diversified pharmaceutical company, and its aesthetics business, Solta Medical, today announced the availability of Fraxel FTX^® in Australia, expanding access to its latest skin resurfacing technology to Australian health care practitioners (HCPs) beginning September 1, 2026.

Building on more than 20 years of innovation in skin resurfacing, Fraxel FTX represents the next

Bausch Health Announces Availability of Solta Medical's Fraxel FTX® in Australia

Tue, 01 Sep 2026 08:01:00 -0400

The next generation in skin resurfacing technology is available to Australian health care practitioners beginning September 1, 2026

Building on more than 20 years of innovation in skin resurfacing, Fraxel FTX represents the next

Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds

Tue, 01 Sep 2026 06:58:00 -0400

Only 14% of peri-, menopausal and post-menopausal women recognize dry eye as a menopause-related symptom.
78% of women were surprised to learn that dry eye is a symptom of perimenopause or menopause.
Women experiencing dry eye reported impacts on everyday activities including reading, screen use, driving and productivity.
Findings underscore the need for greater awareness of the connection between menopause and eye health.

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced findings from a new survey highlighting a significant awareness gap around

Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds

Tue, 01 Sep 2026 06:58:00 -0400

Only 14% of peri-, menopausal and post-menopausal women recognize dry eye as a menopause-related symptom.
78% of women were surprised to learn that dry eye is a symptom of perimenopause or menopause.
Women experiencing dry eye reported impacts on everyday activities including reading, screen use, driving and productivity.
Findings underscore the need for greater awareness of the connection between menopause and eye health.

Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds

Tue, 01 Sep 2026 06:58:00 -0400

Only 14% of peri-, menopausal and post-menopausal women recognize dry eye as a menopause-related symptom.
78% of women were surprised to learn that dry eye is a symptom of perimenopause or menopause.
Women experiencing dry eye reported impacts on everyday activities including reading, screen use, driving and productivity.
Findings underscore the need for greater awareness of the connection between menopause and eye health.

Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds

Tue, 01 Sep 2026 06:58:00 -0400

Only 14% of peri-, menopausal and post-menopausal women recognize dry eye as a menopause-related symptom.
78% of women were surprised to learn that dry eye is a symptom of perimenopause or menopause.
Women experiencing dry eye reported impacts on everyday activities including reading, screen use, driving and productivity.
Findings underscore the need for greater awareness of the connection between menopause and eye health.

Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds

Tue, 01 Sep 2026 06:58:00 -0400

Only 14% of peri-, menopausal and post-menopausal women recognize dry eye as a menopause-related symptom.
78% of women were surprised to learn that dry eye is a symptom of perimenopause or menopause.
Women experiencing dry eye reported impacts on everyday activities including reading, screen use, driving and productivity.
Findings underscore the need for greater awareness of the connection between menopause and eye health.

Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds

Tue, 01 Sep 2026 06:58:00 -0400

Only 14% of peri-, menopausal and post-menopausal women recognize dry eye as a menopause-related symptom.
78% of women were surprised to learn that dry eye is a symptom of perimenopause or menopause.
Women experiencing dry eye reported impacts on everyday activities including reading, screen use, driving and productivity.
Findings underscore the need for greater awareness of the connection between menopause and eye health.

Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners